Join us Saturday, May 30, at the OHSU Center for Health & Healing for our Skin Cancer Research Expo and Sun Safety Event!
The expo differs from many other health events in that it will give community members an opportunity to take part in ongoing research.
The research expo is our first major OHSU melanoma-related event since Sancy Leachman, M.D., Ph.D., director of the OHSU Knight Cancer Institute’s Melanoma Research Program and chair of the OHSU Department of Dermatology, launched the Melanoma Community Registry in May 2014.
The first event was a symposium in November that attracted about 125 patients, friends and family; the registry has grown to more than 3,330 participants since launching.
The registry’s aim is to develop a cohort of survivors, family members and others to help researchers understand how to best prevent, treat and detect melanoma, and the Skin Cancer Research Expo is a significant opportunity to be face-to-face with physicians, scientists, survivors and advocates to help expand those efforts. About 10 researchers, including nine from OHSU, will be on hand to connect with attendees about research opportunities.
Among the researchers participating in the expo:
- Leachman, who will ask survivors and advocates to join the Melanoma Community Registry. She will also have three surveys on hand: one is for all registry members intended to ascertain what information and research projects they would be interested in participating; another asks survivors about their quality of life; and the third is about sunscreen use.
- The OHSU Knight BioLibrary, which will invite all attendees to donate blood for research. Attendees will be invited to join the Personalized Cancer Medicine Registry to become a donor and help grow this vital research resource.
- Paul Spellman, Ph.D., professor of molecular and medical genetics, OHSU School of Medicine, and a researcher in the OHSU Knight Cancer Institute, who will seek blood donations from a subset of melanoma survivors. Free-floating DNA in the blood will be sequenced to determine if researchers can measure tumor DNA in the blood stream with the intention of developing a simple, non-invasive way to detect recurrence of cancer at a much earlier point than is currently possible.
- Andrew Trister, M.D., Ph.D., a senior physician with Sage Bionetworks in Seattle, Wash., and Dan Webster, Ph.D., developer of an iPhone application called Mole Mapper (which measures and tracks moles), who will solicit feedback about the app.
The expo will also include information on how attendees can monitor their skin health, the best sunscreens to use and games for attendees of all ages. OHSU and Portland dermatologists will be on hand to offer free skin checks in a private clinic room, as well.